2008
DOI: 10.1002/ejoc.200700787
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Solid‐Phase Synthesis Techniques for the Preparation of Peptide–Metal Complex Conjugates

Abstract: This microreview summarizes recent reports on the preparation of metal complex peptide conjugates by solid‐phase synthesis methods. Procedures for such conjugates are in many cases different from standard solid‐phase peptide synthesis protocols. Specific advantages of general strategies, the synthesis of peptide–ligand conjugates and complexation with excess metal ions on solid support or the incorporation of previously prepared metal complex amino acid derivatives are discussed.(© Wiley‐VCH Verlag GmbH & Co. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(41 citation statements)
references
References 146 publications
0
40
0
Order By: Relevance
“…25 In recent years, several coordination or organometallic complexes have also been conjugated to carrier molecules such as receptor-binding peptides or known delivery peptides to improve both cellular uptake to cancer cells and cytotoxic activity of the metal-based drug. 26,27,28,29,30,31,32,33 Herein we report on the use of conjugates between octreotide and several metal complexes as new chemotherapeutic agents. In particular, the synthesis of hybrid compounds between the dicarba analogue of octreotide (2) and platinum(II), ruthenium(II) and osmium(II) metal complexes has been accomplished by efficient solid-phase procedures (compounds 3-6 in Chart 1).…”
Section: Acs Paragon Plus Environmentmentioning
confidence: 99%
“…25 In recent years, several coordination or organometallic complexes have also been conjugated to carrier molecules such as receptor-binding peptides or known delivery peptides to improve both cellular uptake to cancer cells and cytotoxic activity of the metal-based drug. 26,27,28,29,30,31,32,33 Herein we report on the use of conjugates between octreotide and several metal complexes as new chemotherapeutic agents. In particular, the synthesis of hybrid compounds between the dicarba analogue of octreotide (2) and platinum(II), ruthenium(II) and osmium(II) metal complexes has been accomplished by efficient solid-phase procedures (compounds 3-6 in Chart 1).…”
Section: Acs Paragon Plus Environmentmentioning
confidence: 99%
“…It would thus be particularly interesting if metal-based markers could also directly be attached to such carrier peptides during the automated solid-phase synthesis protocol with minimal side reactions and purification steps. While redox-active sandwich complexes have been quite frequently used in the labelling of peptides [6][7][8][9][10][11][12][13][14], other functional groups have received somewhat less attention [15][16][17][18][19][20][21][22][23][24]. In addition, most of these functionalities were introduced by manual coupling.…”
Section: Introductionmentioning
confidence: 99%
“…Especially metallocenes have been at the focus of intense research efforts, since, for example, the Fe II/III redox couple as in ferrocene allows for an easy electrochemical quantification of the labelled peptide [1][2][3][4][5][6][7][8][9]. Substantially less work has however been carried out based on other properties of organometallic compounds [10][11][12][13][14][15][16][17][18][19][20][21][22]. We are particularly interested in the attachment of IR spectroscopic labels to peptides for biological imaging applications with scanning near-field IR microscopy (SNIM) [23].…”
Section: Introductionmentioning
confidence: 99%